Radiation therapy
1 – 10 of 314
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC
- Contribution to journal › Article
-
Mark
Chemoradiation Therapy Versus Radiation Therapy Alone in T1-2 Oropharyngeal Cancer With Low-Volume Neck Disease: A Population-Based Cohort Study Using the Swedish Head and Neck Cancer Register
- Contribution to journal › Article
-
Mark
Not All Tumors Are Alike : Varying Efficacy of FLASH Across Tumor Types and Oxygenation Status in Spheroid Models
- Contribution to journal › Article
-
Mark
Paucity of type 2 cytokines and atypical IL-5 receptor alpha patterns during established eosinophilic inflammation in seasonal allergic rhinitis
- Contribution to journal › Article
-
Mark
The association between self-perceived stuttering and social participation among older adults in Sweden: : A population based cross-sectional study
- Contribution to journal › Article
-
Mark
Feasibility of patient-reported outcomes collection in clinical routine at a radiotherapy department
- Contribution to journal › Article
-
Mark
Vitamin K-dependent proteins in patients undergoing head and neck free flap surgery - a prospective observational study
- Contribution to journal › Article
-
Mark
Re: Dries Develtere, Riccardo Bertolo. Cumulative Genitourinary Toxicity After Prostate Radiotherapy: High-Level Long-Term Randomized Evidence. J Clin Oncol. Online ahead of print. http://dx.doi.org/10.1200/JCO-26-00436
(2026) In European Urology
- Contribution to journal › Letter
-
Mark
External Validation of Pre-Treatment Primary Tumor Volume as a Prognostic Factor in Head and Neck Cancer Treated With (Chemo)Radiotherapy
(2026) In Head and Neck
- Contribution to journal › Article
-
Mark
Daily adaptive radiotherapy in head and neck squamous cell carcinoma can negatively impact organ at risk dosimetry
- Contribution to journal › Article
